Hans Chuang
About Hans Chuang
Hans Chuang is an Associate Director of Market Planning and Analysis at Aimmune Therapeutics, with a background in forecasting and business analysis from his previous roles at Amgen and Genentech. He holds an MBA from Carnegie Mellon University and a BA in Biology from the University of California, Berkeley.
Current Role at Aimmune Therapeutics
Hans Chuang serves as the Associate Director of Market Planning and Analysis at Aimmune Therapeutics. He has held this position since 2018, contributing to the company's strategic market initiatives. His role involves analyzing market trends and developing plans that align with the company's objectives in the biopharmaceutical sector. Aimmune Therapeutics focuses on developing treatments for food allergies, and Chuang's expertise supports the company's mission.
Previous Experience at Amgen
Chuang worked at Amgen in various capacities from 2009 to 2013. He began as a Specialist in Pricing and Contracting, where he focused on pricing strategies and contract negotiations. He then advanced to the role of Senior Manager in Forecasting, where he was responsible for developing sales forecasts and market analyses. His tenure at Amgen provided him with significant experience in the biotechnology industry.
Education and Expertise
Hans Chuang holds a Master of Business Administration from Carnegie Mellon University, where he studied Marketing, Accounting, and Finance from 2001 to 2003. He also earned a Bachelor of Arts in Biology from the University of California, Berkeley, completing his studies from 1992 to 1996. His educational background equips him with a strong foundation in both scientific and business disciplines, enhancing his analytical capabilities in market planning.
Career Background
Chuang's career spans multiple industries and roles. Before joining Aimmune Therapeutics, he worked at Genentech as a Senior Manager in Forecasting and Business Analysis from 2013 to 2018. He also held positions at J.P. Morgan as an Associate in Equity Derivatives from 2006 to 2008 and at Allianz as an Assistant Manager from 2004 to 2006. This diverse background has contributed to his comprehensive understanding of market dynamics.